 <h1>Oxytrol Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>oxybutynin</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about oxybutynin. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Oxytrol.</p><h2>In Summary</h2><p><b>Common side effects of Oxytrol include:</b> local pruritus.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to oxybutynin: oral syrup, oral tablet, oral tablet extended release</i></p><p>Other dosage forms:</p><ul><li>transdermal gel/jelly, transdermal patch extended release</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, oxybutynin (the active ingredient contained in Oxytrol) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking oxybutynin:</p><p>
<i>Rare</i>
</p><ul>
<li>Eye pain</li>
<li>skin rash or hives</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking oxybutynin:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Clumsiness or unsteadiness</li>
<li>confusion</li>
<li>convulsions</li>
<li>dizziness</li>
<li>drowsiness (severe)</li>
<li>fainting</li>
<li>fast, slow, or irregular heartbeat</li>
<li>fever</li>
<li>flushing or redness of the face</li>
<li>hallucinations (seeing, hearing, or feeling things that are not there)</li>
<li>troubled breathing</li>
<li>unusual excitement, nervousness, restlessness, or irritability</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of oxybutynin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>decreased sweating</li>
<li>diarrhea</li>
<li>difficulty having a bowel movement (stool)</li>
<li>drowsiness</li>
<li>dryness of the eyes, mouth, nose, or throat</li>
<li>heartburn</li>
<li>indigestion</li>
<li>runny nose</li>
<li>stomach discomfort, upset, or pain</li>
</ul><p>
<i>Less common or rare</i>
</p><ul>
<li>Blurred vision</li>
<li>decreased flow of breast milk</li>
<li>decreased sexual ability</li>
<li>difficulty in swallowing</li>
<li>feeling of warmth or heat</li>
<li>headache</li>
<li>increased sensitivity of the eyes to light</li>
<li>nausea or vomiting</li>
<li>trouble with sleeping</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>decreased interest in sexual intercourse</li>
<li>inability to have or keep an erection</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>rapid weight gain</li>
<li>tingling of the hands or feet</li>
<li>unusual weight gain or loss</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to oxybutynin: oral syrup, oral tablet, oral tablet extended release, transdermal film extended release, transdermal gel</i></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity</p>
<p><b>Frequency not reported</b>: Anaphylactic reaction<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Palpitations</p>
<p><b>Uncommon</b> (0.1% to 1%): Cardiac arrhythmia tachycardia, vasodilation, hypertension, flushing</p>
<p><b>Frequency not reported</b>: Heat stroke<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Dry skin, pruritus</p>
<p><b>Common</b> (1% to 10%): Flushing, rash</p>
<p><b>Frequency not reported</b>: Angioedema, hypohidrosis<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Postmarketing reports</b>: Decreased lactation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dry mouth (up to 72%), constipation (up to 15%), nausea</p>
<p><b>Common</b> (1% to 10%): Diarrhea, dyspepsia, abdominal pain, vomiting, flatulence, gastroesophageal reflux disease</p>
<p><b>Uncommon</b> (0.1% to 1%): Abdominal discomfort</p>
<p><b>Frequency not reported</b>: Pseudo-obstruction in patients at risk (elderly or patients with constipation and treated with other drugs that decrease intestinal motility), decreased GI motility<sup>[Ref]</sup></p><h3>General</h3><p>The most common (incidence 5% or greater) adverse reactions were dry mouth, constipation, diarrhea, headache, somnolence, and dizziness.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, urinary hesitation, urinary retention, dysuria, increased post void retention</p>
<p><b>Frequency not reported</b>: Impotence, suppression of lactation, cystitis, aggravation of prostatic hypertrophy<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Fungal infection<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Application site pruritus (16.8%)</p>
<p><b>Common</b> (1% to 10%): Application site erythema, application site vesicles, application site rash, application site macules<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Anorexia, fluid retention<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Back pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (up to 17%), somnolence (up to 14%), headache, drowsiness, confusion</p>
<p><b>Common</b> (1% to 10%): Dysgeusia</p>
<p><b>Uncommon</b> (0.1% to 1%): Dysphagia, convulsions</p>
<p><b>Frequency not reported</b>: Cognitive disorders in elderly, convulsions, agitation, nightmares, anxiety, paranoia, symptoms of depression, hallucinations, asthenia, insomnia, restlessness, dependence to this drug (in patients with history of drug or substance abuse)<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision, dry eye, abnormal vision</p>
<p><b>Uncommon</b> (0.1% to 1%): Angle closure glaucoma</p>
<p><b>Frequency not reported</b>: Onset of narrow-angle glaucoma, mydriasis, intraocular hypertension, amblyopia, cycloplegia, decreased lacrimation<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue</p>
<p><b>Uncommon</b> (0.1% to 1%): Dysphonia, thirst</p>
<p><b>Frequency not reported</b>: Falls, accidental injury<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, nervousness</p>
<p><b>Uncommon</b> (0.1% to 1%): Hallucinations, confusional state, agitation, memory impairment </p>
<p><b>Frequency not reported</b>: Psychotic disorder, anxiety, nightmares, paranoia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Cough, oropharyngeal pain, dry throat, nasal dryness</p>
<p><b>Uncommon</b> (0.1% to 1%): Upper respiratory tract infection, rhinitis, chest discomfort, hoarseness</p>
<p><b>Rare</b> (0.01% to 0.1%): Nasal congestion, throat irritation<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Ditropan (oxybutynin)." Hoechst Marion-Roussel Inc, Kansas City, MO. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Oxytrol (oxybutynin)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>73 Reviews</li>
<li>Drug class: urinary antispasmodics</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Oxytrol &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Ditropan, Ditropan XL, Gelnique, Anturol</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Urinary Incontinence</li>
<li>Dysuria</li>
<li>Urinary Frequency</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to oxybutynin: oral syrup, oral tablet, oral tablet extended release, transdermal film extended release, transdermal gel</i></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity</p><p><b>Frequency not reported</b>: Anaphylactic reaction<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Palpitations</p><p><b>Uncommon</b> (0.1% to 1%): Cardiac arrhythmia tachycardia, vasodilation, hypertension, flushing</p><p><b>Frequency not reported</b>: Heat stroke<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Dry skin, pruritus</p><p><b>Common</b> (1% to 10%): Flushing, rash</p><p><b>Frequency not reported</b>: Angioedema, hypohidrosis<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Postmarketing reports</b>: Decreased lactation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dry mouth (up to 72%), constipation (up to 15%), nausea</p><p><b>Common</b> (1% to 10%): Diarrhea, dyspepsia, abdominal pain, vomiting, flatulence, gastroesophageal reflux disease</p><p><b>Uncommon</b> (0.1% to 1%): Abdominal discomfort</p><p><b>Frequency not reported</b>: Pseudo-obstruction in patients at risk (elderly or patients with constipation and treated with other drugs that decrease intestinal motility), decreased GI motility<sup>[Ref]</sup></p><h3>General</h3><p>The most common (incidence 5% or greater) adverse reactions were dry mouth, constipation, diarrhea, headache, somnolence, and dizziness.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, urinary hesitation, urinary retention, dysuria, increased post void retention</p><p><b>Frequency not reported</b>: Impotence, suppression of lactation, cystitis, aggravation of prostatic hypertrophy<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Fungal infection<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Application site pruritus (16.8%)</p><p><b>Common</b> (1% to 10%): Application site erythema, application site vesicles, application site rash, application site macules<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Anorexia, fluid retention<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Back pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (up to 17%), somnolence (up to 14%), headache, drowsiness, confusion</p><p><b>Common</b> (1% to 10%): Dysgeusia</p><p><b>Uncommon</b> (0.1% to 1%): Dysphagia, convulsions</p><p><b>Frequency not reported</b>: Cognitive disorders in elderly, convulsions, agitation, nightmares, anxiety, paranoia, symptoms of depression, hallucinations, asthenia, insomnia, restlessness, dependence to this drug (in patients with history of drug or substance abuse)<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision, dry eye, abnormal vision</p><p><b>Uncommon</b> (0.1% to 1%): Angle closure glaucoma</p><p><b>Frequency not reported</b>: Onset of narrow-angle glaucoma, mydriasis, intraocular hypertension, amblyopia, cycloplegia, decreased lacrimation<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue</p><p><b>Uncommon</b> (0.1% to 1%): Dysphonia, thirst</p><p><b>Frequency not reported</b>: Falls, accidental injury<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, nervousness</p><p><b>Uncommon</b> (0.1% to 1%): Hallucinations, confusional state, agitation, memory impairment </p><p><b>Frequency not reported</b>: Psychotic disorder, anxiety, nightmares, paranoia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Cough, oropharyngeal pain, dry throat, nasal dryness</p><p><b>Uncommon</b> (0.1% to 1%): Upper respiratory tract infection, rhinitis, chest discomfort, hoarseness</p><p><b>Rare</b> (0.01% to 0.1%): Nasal congestion, throat irritation<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Ditropan (oxybutynin)." Hoechst Marion-Roussel Inc, Kansas City, MO. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><h2>More about Oxytrol (oxybutynin)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>73 Reviews</li>
<li>Drug class: urinary antispasmodics</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Oxytrol &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Urinary Incontinence</li>
<li>Dysuria</li>
<li>Urinary Frequency</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>